Date Tuesday, March 25, 2025

Place

Auditorium Plaza Mandiri Lantai 3 Plaza Mandiri, Jl. Jend. Gatot Subroto Kav. 36-38, Jakarta Selatan 12190

Time

14:00 WIB

Agenda

RUPST:

  1. Approval of the Annual Report and Ratification of the Company's Consolidated Financial Statements, Approval of the Board of Commissioners Oversight Report and Ratification of the Financial Statements of the Micro and Small Business Funding Program (“PUMK”) for the Financial Year 2024, and to release and discharge of all responsibilities (volledig acquit et de charge) to all Board members for the management and supervision carried out during the Financial Year 2024.
  2. Approval of the use of the Company's Net Income for the Financial Year 2024
  3. Determination of Salary/Honorarium and Facilities and Benefits for the Financial Year 2025, and Tantiem/Performance Incentive/Special Incentive for the Performance of the Financial Year 2024 and/or Long-Term Incentive for the Period of 2025-2027, for the Board of Directors and Board of Commissioners of the Company.
  4. Appointment of Public Accountant and/or Public Accounting Firm to audit the Company's Consolidated Financial Statements and Financial Statements of the PUMK Program for the Financial Year 2025.
  5. Approval of the Company's Recovery Plan Update.
  6. Approval of Amendments to the Company's Articles of Association.
  7. Approval of the Company's Share Buyback Plan and the Transfer of Buyback Shares Held as Treasury Stock.
  8. Changes in the Composition of the Company's Management.

DH/LM

BMRI - PT. Bank Mandiri (Persero) Tbk

Rp 4.690

-50 (-1,06%)